Neoadjuvant randomized trial of degarelix (Deg) +/- cyclophosphamide/GVAX (Cy/GVAX) in men with high-risk prostate cancer (PCa) undergoing radical prostatectomy (RP).

Antonarakis E. S., Zahurak M., Schaeffer E. M., Partin A. W., Ross A., Allaf M., ...More

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35

Publication Type: Conference Paper / Summary Text
Volume: 35
Doi Number: 10.1200/jco.2017.35.15_suppl.5077
City: Illinois
Country: United States Of America
Hacettepe University Affiliated: No